Next Article in Journal
In Silico Design of E3 Ubiquitin-Protein Ligase NEDD4-1 Inhibitors: An Alternative Approach for Targeting the MAPK Pathway in Cancer Therapy
Previous Article in Journal
Repositioning of Dantrolene as a Multitarget Agent for Neurodegenerative Diseases
Open AccessExtended Abstract

A Novel Series of Sialic Acid-Based Influenza Virus Inhibitors that Target Influenza Virus Neuraminidase

Institute for Glycomics, Griffith University, Gold Coast, Queensland 4222, Australia
Presented at the 2nd Molecules Medicinal Chemistry Symposium (MMCS): Facing Novel Challenges in Drug Discovery, Barcelona, Spain, 15–17 May 2019.
Proceedings 2019, 22(1), 8;
Published: 7 August 2019
(This article belongs to the Proceedings of The Molecules Medicinal Chemistry Symposium)
PDF [148 KB, uploaded 7 August 2019]
Note: In lieu of an abstract, this is an excerpt from the first page.


Influenza virus continues to be a clinically-significant human pathogen that causes both
epidemics and pandemics. Successful inhibition of the viral neuraminidase hinders the release of
virion progeny from the infected host cell and significantly reduces further virus spread [...]
Keywords: Influenza; Neuraminidase; Inhibitors Influenza; Neuraminidase; Inhibitors
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

von Itzstein, M. A Novel Series of Sialic Acid-Based Influenza Virus Inhibitors that Target Influenza Virus Neuraminidase. Proceedings 2019, 22, 8.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics



[Return to top]
Proceedings EISSN 2504-3900 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top